For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Cytokinetics Inc (NASDAQ: CYTK) closed at $37.93 in the last session, down -3.93% from day before closing price of $39.48. In other words, the price has decreased by -$3.93 from its previous closing price. On the day, 1.88 million shares were traded. CYTK stock price reached its highest trading level at $39.285 during the session, while it also had its lowest trading level at $37.4501.
Ratios:
We take a closer look at CYTK’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.17 and its Current Ratio is at 6.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on February 07, 2025, initiated with a Buy rating and assigned the stock a target price of $86.
On January 22, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $80.
On November 08, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $80.RBC Capital Mkts initiated its Outperform rating on November 08, 2024, with a $80 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 21 ’25 when WIERENGA WENDALL sold 20,000 shares for $38.46 per share. The transaction valued at 769,200 led to the insider holds 24,848 shares of the business.
WENDELL WIERENGA bought 20,000 shares of CYTK for $769,144 on Apr 21 ’25. On Apr 15 ’25, another insider, HENDERSON JOHN T, who serves as the Director of the company, sold 3,190 shares for $38.66 each. As a result, the insider received 123,325 and left with 66,348 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYTK now has a Market Capitalization of 4705520128 and an Enterprise Value of 4338484224. For the stock, the TTM Price-to-Sale (P/S) ratio is 244.76. Its current Enterprise Value per Revenue stands at 234.843 whereas that against EBITDA is -8.237.
Stock Price History:
The Beta on a monthly basis for CYTK is 0.83, which has changed by -0.42153424 over the last 52 weeks, in comparison to a change of 0.017286062 over the same period for the S&P500. Over the past 52 weeks, CYTK has reached a high of $68.76, while it has fallen to a 52-week low of $32.74. The 50-Day Moving Average of the stock is -11.32%, while the 200-Day Moving Average is calculated to be -24.70%.
Shares Statistics:
According to the various share statistics, CYTK traded on average about 1.98M shares per day over the past 3-months and 2552120 shares per day over the past 10 days. A total of 118.21M shares are outstanding, with a floating share count of 116.04M. Insiders hold about 2.64% of the company’s shares, while institutions hold 109.38% stake in the company. Shares short for CYTK as of 1743379200 were 14333413 with a Short Ratio of 7.24, compared to 1740700800 on 14072458. Therefore, it implies a Short% of Shares Outstanding of 14333413 and a Short% of Float of 18.43.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
